Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
4
×
fda
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
bristol-myers squibb
cancer
pfizer
startups
allergan
alzheimer's disease
avexis
biogen
What
bio
roundup
4
×
biotech
companies
drug
fda
news
week
alzheimer’s
annual
approved
assessed
attention
august
black
busy
communities
conference
continue
days
debut
decisions
devices
diamond
diamond’s
digital
disease
drugs
epidemic
esmo
europe
fatty
frenzied
germany
growing
hosted
indication
investment
known
leading
Language
unset
Current search:
fda
×
roundup
×
biotech
×
" eli lilly "
×
abbvie
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More